MNPR R&D Expenses

Monopar Therapeutics Inc · R&D Expenses

MNPR logo

MNPR R&D Expenses

Latest reported$4.77M
MNPR Quarterly R&D Expenses ($56.91K → $4.77M)
High-resolution chart · PNG

MNPR r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monopar Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
4,766,832
3,487,247
3,941,101
2,589,749
1,730,000
1,643,375
9,924,620
984,278
1,130,978
966,110
1,035,591
1,316,520
1,594,713
1,653,369
2,102,968
1,732,230
2,078,471
1,677,932
1,982,677
1,827,322
1,476,430
1,206,779
1,632,373
1,255,916
832,503
344,407
583,778
219,846
329,294
835,600
520,982
303,684
492,647
457,141
309,315
14,682,000
311,593
133,736
97,328
69,200
56,913
56,914
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.